Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral dosage form for systemic use. It is employed to manage high blood pressure, chest pain due to angina, and certain rapid heart rhythms in adult patients.

GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable lead times and dedicated technical support throughout the procurement process.

Verapamil is used to treat cardiovascular conditions that involve elevated vascular tone or abnormal cardiac conduction. - Hypertension: lowers blood pressure by dilating peripheral arteries. - Angina pectoris: reduces myocardial oxygen demand and alleviates chest pain. - Supraventricular tachyarrhythmias (e.g., atrial fibrillation, atrial flutter): slows atrioventricular nodal conduction to control heart rate.

Verapamil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Dizziness or light‑headedness: due to lowered blood pressure. - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Nausea: occasional stomach upset. - Flushing: transient warmth and reddening of skin.

Serious or Rare Side Effects: - Bradycardia: excessively slow heart rate that may require medical attention. - Heart block: impairment of electrical conduction between atria and ventricles. - Severe hypotension: sudden drop in blood pressure causing fainting or shock.

When prescribing Verapamil, clinicians should evaluate patient history and monitor for specific safety concerns. - Cardiac function: avoid use in patients with severe left ventricular dysfunction or heart failure. - Conduction disorders: contraindicated in individuals with second‑ or third‑degree AV block without a pacemaker. - Hepatic impairment: dose adjustment may be required in moderate to severe liver disease. - Drug interactions: review concomitant medications that affect cytochrome P450 enzymes. - Pregnancy: category B1; use only if potential benefit justifies potential risk to the fetus. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Verapamil interacts with several medicines; understanding the interaction level guides clinical decisions.

Major Interactions (Avoid): - Beta‑blockers (e.g., propranolol): combined use can cause profound bradycardia and heart block. - Digoxin: increased serum digoxin levels may lead to toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can markedly raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): additive blood‑pressure lowering effect. - Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): may increase statin exposure and risk of myopathy. - Calcium supplements or antacids: can reduce oral absorption of verapamil.